Page last updated: 2024-09-02

ramosetron and Ovarian Neoplasms

ramosetron has been researched along with Ovarian Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chuma, M; Goda, M; Hamada, Y; Hamano, H; Hayama, T; Horinouchi, Y; Ikeda, Y; Imai, T; Ishida, S; Ishizawa, K; Kirino, Y; Mitsuhashi, C; Nakamura, T; Niimura, T; Okada, N; Sakamoto, K; Shinomiya, K; Suzuki, Y; Takechi, K; Tsujinaka, K; Yagi, K; Yanagawa, H; Zamami, Y	1
Bae, DS; Choi, CH; Kim, BG; Kim, HJ; Kim, MK; Kim, TJ; Lee, JW; Lee, YY; Park, JY; Yoon, A	1
Nakayama, S; Noda, T; Torii, Y	1

Trials

2 trial(s) available for ramosetron and Ovarian Neoplasms

Article	Year
Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Benzimidazoles; Carboplatin; Dexamethasone; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Morpholines; Nausea; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Vomiting; Young Adult	2014
[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8 Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Endometrial Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory	2001

Article

Year

Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Benzimidazoles; Carboplatin; Dexamethasone; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Morpholines; Nausea; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Vomiting; Young Adult

2014

[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8

Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Endometrial Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory

2001

Other Studies

1 other study(ies) available for ramosetron and Ovarian Neoplasms

Article	Year
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:4 Topics: Adult; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bleomycin; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Palonosetron; Platinum Compounds; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Testicular Neoplasms; Vomiting	2021

Article

Year

Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study.

Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:4

Topics: Adult; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bleomycin; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Palonosetron; Platinum Compounds; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Testicular Neoplasms; Vomiting

2021